U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Alpha-2-plasmin inhibitor deficiency

MedGen UID:
414178
Concept ID:
C2752081
Disease or Syndrome
Synonyms: Anti-plasmin deficiency, congenital; ANTIPLASMIN DEFICIENCY; PLASMIN INHIBITOR DEFICIENCY
Modes of inheritance:
Autosomal recessive inheritance
MedGen UID:
141025
Concept ID:
C0441748
Intellectual Product
Source: Orphanet
A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in individuals with two pathogenic alleles, either homozygotes (two copies of the same mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele).
 
Gene (location): SERPINF2 (17p13.3)
 
Monarch Initiative: MONDO:0009883
OMIM®: 262850
Orphanet: ORPHA79

Definition

Alpha-2-plasmin inhibitor deficiency is a rare autosomal recessive hemorrhagic diathesis. Most bleeds are severe, appear during childhood, and, in a few cases, umbilical bleeding is the first manifestation. Some homozygous patients present only moderate bleeding (Favier et al., 2001). [from OMIM]

Clinical features

From HPO
Joint hemorrhage
MedGen UID:
5479
Concept ID:
C0018924
Pathologic Function
Hemorrhage occurring within a joint.
Persistent bleeding after trauma
MedGen UID:
375403
Concept ID:
C1844374
Finding
Hemothorax
MedGen UID:
5510
Concept ID:
C0019123
Pathologic Function
The presence of blood in the pleural space.
Bruising susceptibility
MedGen UID:
140849
Concept ID:
C0423798
Finding
An ecchymosis (bruise) refers to the skin discoloration caused by the escape of blood into the tissues from ruptured blood vessels. This term refers to an abnormally increased susceptibility to bruising. The corresponding phenotypic abnormality is generally elicited on medical history as a report of frequent ecchymoses or bruising without adequate trauma.

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVAlpha-2-plasmin inhibitor deficiency

Professional guidelines

PubMed

Schwartz BS, Williams EC, Conlan MG, Mosher DF
Ann Intern Med 1986 Dec;105(6):873-7. doi: 10.7326/0003-4819-105-6-873. PMID: 3465267

Recent clinical studies

Etiology

Brands-Nijenhuis AV, van Geel PP, Meijer K
Blood Coagul Fibrinolysis 2009 Oct;20(7):599-600. doi: 10.1097/MBC.0b013e32832d9b33. PMID: 19593116
Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E
Hematol Oncol 2008 Dec;26(4):241-6. doi: 10.1002/hon.867. PMID: 18613223Free PMC Article
Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y
Neurosurgery 2001 Nov;49(5):1084-9; discussion 1089-90. doi: 10.1097/00006123-200111000-00011. PMID: 11846901
Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L
Leukemia 1995 Jan;9(1):19-24. PMID: 7531260
Schwartz BS, Williams EC, Conlan MG, Mosher DF
Ann Intern Med 1986 Dec;105(6):873-7. doi: 10.7326/0003-4819-105-6-873. PMID: 3465267

Diagnosis

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E
Hematol Oncol 2008 Dec;26(4):241-6. doi: 10.1002/hon.867. PMID: 18613223Free PMC Article
Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y
Neurosurgery 2001 Nov;49(5):1084-9; discussion 1089-90. doi: 10.1097/00006123-200111000-00011. PMID: 11846901
Miura O, Sugahara Y, Aoki N
J Biol Chem 1989 Oct 25;264(30):18213-9. PMID: 2572590

Therapy

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E
Hematol Oncol 2008 Dec;26(4):241-6. doi: 10.1002/hon.867. PMID: 18613223Free PMC Article
Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L
Leukemia 1995 Jan;9(1):19-24. PMID: 7531260
Takahashi Y, Tanaka T, Nakajima N, Yoshioka A, Fukui H, Miyauchi Y, Mii Y, Tamai S
Haemostasis 1991;21(5):321-7. doi: 10.1159/000216243. PMID: 1806461
Schwartz BS, Williams EC, Conlan MG, Mosher DF
Ann Intern Med 1986 Dec;105(6):873-7. doi: 10.7326/0003-4819-105-6-873. PMID: 3465267
Meyer K, Williams EC
Am J Med 1985 Sep;79(3):394-6. doi: 10.1016/0002-9343(85)90321-3. PMID: 4036990

Prognosis

Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y
Neurosurgery 2001 Nov;49(5):1084-9; discussion 1089-90. doi: 10.1097/00006123-200111000-00011. PMID: 11846901
Schwartz BS, Williams EC, Conlan MG, Mosher DF
Ann Intern Med 1986 Dec;105(6):873-7. doi: 10.7326/0003-4819-105-6-873. PMID: 3465267

Clinical prediction guides

Wassenaar T, Black J, Kahl B, Schwartz B, Longo W, Mosher D, Williams E
Hematol Oncol 2008 Dec;26(4):241-6. doi: 10.1002/hon.867. PMID: 18613223Free PMC Article
Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y
Neurosurgery 2001 Nov;49(5):1084-9; discussion 1089-90. doi: 10.1097/00006123-200111000-00011. PMID: 11846901
Dombret H, Scrobohaci ML, Daniel MT, Micléa JM, Castaigne S, Chomienne C, Fenaux P, Degos L
Leukemia 1995 Jan;9(1):19-24. PMID: 7531260
Schwartz BS, Williams EC, Conlan MG, Mosher DF
Ann Intern Med 1986 Dec;105(6):873-7. doi: 10.7326/0003-4819-105-6-873. PMID: 3465267

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...